Microglia phagocytic mechanisms: Development informing disease

Rebecca M Beiter1, Patrick W Sheehan1, Dorothy P Schafer1

  • 1Department of Neurobiology, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.

PubMed

Insights

Microglia, the brain's immune cells, use phagocytosis to sculpt the nervous system during development. This same process is crucial for clearing debris in neurodegenerative diseases, offering therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells of the central nervous system (CNS), acting as professional phagocytes.
  • During development, microglia-mediated phagocytosis is essential for shaping neural architecture, including synapse and myelin pruning.
  • These phagocytic functions are increasingly recognized for their role in clearing cellular debris and pathological proteins during neurodegeneration.

Purpose of the Study:

  • To highlight the parallels between microglial functions in neurodevelopment and neurodegeneration.
  • To explore how understanding neurodevelopment can inform therapeutic strategies for neurological diseases.
  • To discuss current advances and challenges in therapeutically targeting microglial phagocytosis.

Main Methods:

  • Comparative analysis of microglial phagocytic roles in distinct physiological and pathological contexts.
  • Review of recent scientific literature on neurodevelopment, neurodegeneration, and therapeutic targeting of microglial pathways.

Main Results:

  • Significant overlap exists between the phagocytic mechanisms employed by microglia during CNS development and in the context of neurodegeneration.
  • Developmental processes provide a framework for understanding and potentially manipulating microglial functions in disease.
  • Therapeutic targeting of microglial phagocytosis presents both opportunities and significant challenges.

Conclusions:

  • Leveraging insights from neurodevelopment offers a promising avenue for developing novel therapies for neurodegenerative diseases.
  • Further research is needed to overcome challenges associated with therapeutically modulating microglial phagocytic pathways.
  • Understanding the dual role of microglia in development and disease is key to advancing CNS therapeutics.